CD19 CAR-T Cells with CRS Suppression Technology

· Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19 CAR-T Cells with CRS Suppression Technology, covering 2024-05-28 to 2024-05-28. Get the full timeline:

Most recent: Clinical Trial Update: CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia [Phase 1, Phase 2]